RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®
RedHill received Notices of Allowance from the United States Patent and Trademark Office (USPTO) for two new patents covering BEKINDA® (RHB-102), expected to be valid until at least 2034, once…